Whole Body Magnetic Resonance Imaging
Showing 1 - 25 of >10,000
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, genetic, other)
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 19, 2023
Neurofibromatosis Type 1 Trial in Los Angeles (Whole-body Magnetic Resonance Imaging)
Recruiting
- Neurofibromatosis Type 1
- Whole-body Magnetic Resonance Imaging
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 11, 2022
Development to Predict Malignant Conversion in Neurofibromatosis
Recruiting
- Neurofibromatosis 1
- +2 more
- Whole Body Magnetic Resonance Imaging
-
Baltimore, MarylandJohns Hopkins University
Dec 22, 2022
Multiple Myeloma Trial in Rochester (procedure, biological, drug)
Not yet recruiting
- Multiple Myeloma
- Biospecimen Collection
- +12 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 15, 2023
High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy
Completed
- High Risk Prostate Cancer
- Whole body contrast enhanced computer tomography
- +4 more
-
Turku, FinlandDepartment of Urology
May 3, 2022
Whole Body Magnetic Resonance Imaging Study
Active, not recruiting
- Advanced Prostate Cancer
- WB-MRI
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
May 18, 2021
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
Completed
- Li-Fraumeni Syndrome
- Whole body MRI
- Psychological questionnaires
-
Sutton, Surrey, United KingdomCancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022
Dynamic Whole Body PET/ MRI
Not yet recruiting
- Prostatic Cancer
-
Vancouver, British Columbia, CanadaBC Cancer
Mar 15, 2022
Metastatic Advanced Prostate Cancer
Not yet recruiting
- Advanced Prostate Carcinoma
- Post-treatment CT-guided bone marrow biopsy
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Jul 21, 2021
Peritoneal Carcinomatosis, Peritoneal Metastases, Appendix Cancer Trial in Montréal, Quebec City (Whole-body diffusion-weighted
Recruiting
- Peritoneal Carcinomatosis
- +4 more
- Whole-body diffusion-weighted magnetic resonance imaging
-
Montréal, Quebec, Canada
- +1 more
Nov 16, 2022
Ataxia Telangiectasia Trial in Nottingham (Magnetic Resonance Imaging and an optional blood test)
Not yet recruiting
- Ataxia Telangiectasia
- Magnetic Resonance Imaging and an optional blood test
-
Nottingham, United KingdomUniversity of Nottingham
May 31, 2022
Prostate Cancer Metastatic Trial in Barcelona (Whole-Body Diffusion Weighted MRI)
Recruiting
- Prostate Cancer Metastatic
- Whole-Body Diffusion Weighted MRI
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Oct 13, 2021
Image, Body Trial in Durham (Optical Coherence Tomography (OCT), Magnetic resonance imaging (MRI))
Terminated
- Image, Body
- Optical Coherence Tomography (OCT)
- Magnetic resonance imaging (MRI)
-
Durham, North CarolinaDuke University Duke Eye Center
Mar 11, 2022
Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreas Adenocarcinoma, Peritoneal Metastases Trial in Quebec City (Whole-body
Recruiting
- Pancreas Cancer, Duct Cell Adenocarcinoma
- +3 more
- Whole-body diffusion-weighted magnetic resonance imaging
-
Quebec City, Quebec, CanadaCHU de Québec
Apr 20, 2022
Cancer Trial in Stanford (WB-DW-MR scan, 18-F-FDG PET scan, Ferumoxytol)
Recruiting
- Cancer
- WB-DW-MR scan
- +3 more
-
Stanford, CaliforniaStanford University Cancer Institute
Sep 1, 2021
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 89Zr-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
Prostate Carcinoma Trial in Houston (Bone Scan, Computed Tomography, Magnetic Resonance Imaging)
Recruiting
- Prostate Carcinoma
- Bone Scan
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 4, 2020
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene
Recruiting
- Prostate Cancer
- +2 more
- MRI pelvis or CT imaging
- +2 more
-
London, Sutton, Surrey, United KingdomCancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022
Myeloma Trial in Sutton, London (Machine Learning (ML))
Active, not recruiting
- Myeloma
- Machine Learning (ML)
-
Sutton, Surrey, United Kingdom
- +2 more
Jan 7, 2022
Twins MR Imaging Study
Not yet recruiting
- Aging
- Magnetic Resonance Imaging
-
London, United KingdomKing's College London
Aug 23, 2023
A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging
Recruiting
- Heart Aneurysm
- Superparamagnetic Iron Oxide Nanoparticles
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Nov 18, 2023
Precision Medicine for Liver Tumours With Quantitative Magnetic
Active, not recruiting
- Liver Cancer
- Liver Metastasis Colon Cancer
- utility of whole genome sequencing (WGS) to aid clinical decision making in patients referred for liver resection
-
Basingstoke, Hampshire, United KingdomBasingstoke and North Hampshire Hospital
Nov 1, 2022
Benign Breast Tumor, Breast Carcinoma, Malignant Breast Tumor Trial in Los Angeles (Diffusion Weighted Imaging, Magnetic
Completed
- Benign Breast Neoplasm
- +2 more
- Diffusion Weighted Imaging
- Magnetic Resonance Spectroscopic Imaging
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (procedure, drug, radiation)
Not yet recruiting
- Breast Carcinoma
- Colorectal Carcinoma
- Biopsy
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 8, 2023